- World rank, all time
- #35,133 of 42,892
- Rank in Austria
- #242 of 287
- Research works
- 166 ▼ 46% vs 2013–17
- Citations
- 2.2k 13.1 per fractional work
- Top-10% rate
- 40.0% record average 16.5%
- Open access
- 7% world 28%
What is Austrian Atherosclerosis Society known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| Health SciencesDomain | #17,666 of 20,462 | 9.9% | 121 |
Each strip is that field’s whole ranked pool, with the notch where Austrian Atherosclerosis Society sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Who are the top researchers at Austrian Atherosclerosis Society?
Ranked on the composite score, H Sinzinger, J Kaliman and P Fitscha lead among researchers whose main affiliation is Austrian Atherosclerosis Society.
- 1 H Sinzinger Austria · #1,157,761 worldwide 27 citations · 54 works
- 2 J Kaliman Austria · #1,241,226 worldwide 15 citations · 24 works
- 3 P Fitscha Austria · #1,391,403 worldwide 10 citations · 24 works
Which keywords describe research at Austrian Atherosclerosis Society?
By fractional works in all years, weighted toward what it does more of than the world: Inflammation, Atherosclerosis, Cancer, Clinical Trials, Cardiovascular Risk, Cardiovascular Disease, Statins and Oxidative Stress.
- Nuclear Receptors
- Hemostasis
- Magnetic Resonance Imaging
- Lipid Peroxidation
- Insulin Resistance
- Thrombosis
- Epoxyeicosatrienoic Acids
- Arachidonic Acid
- Diabetes
- Metabolic Syndrome
- Aspirin
- Cholesterol-lowering
- Genetic Variants
- Cardiovascular Events
- Cyclooxygenase-2 Inhibitors
- Genetic Polymorphisms
- Statins
- Cardiovascular Risk
- Clinical Trials
- Atherosclerosis
- Inflammation
- Cancer
- Oxidative Stress
- Cardiovascular Disease
- C-Reactive Protein
- Metabolism
- Prostaglandins
- Obesity
- Cardiovascular Disease Prevention
- Percutaneous Coronary Intervention
- Clopidogrel
- Hypertension
- Cytochrome P450
- Biomarkers
- Cholesterol
- Reactive Oxygen Species
- Endothelial Dysfunction
- Antioxidants
- Cardiovascular Risk Assessment
- Transcriptional Regulation
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Inflammation47▲ 12×30 topics
- Atherosclerosis20▲ 33×11 topics
- Cancer20▲ 8.4×11 topics
- Clinical Trials18▲ 17×5 topics
- Oxidative Stress16▲ 5.4×26 topics
- Cardiovascular Risk16▲ 27×6 topics
- Cardiovascular Disease15▲ 8.3×25 topics
- Statins15▲ 113×2 topics
- C-Reactive Protein13▲ 93×2 topics
- Genetic Polymorphisms13▲ 93×4 topics
- Metabolism13▲ 12×12 topics
- Cyclooxygenase-2 Inhibitors12▲ 195×1 topic
- Prostaglandins12▲ 195×1 topic
- Cardiovascular Events12▲ 43×3 topics
- Obesity12▲ 9.4×11 topics
- Genetic Variants12▲ 33×2 topics
- Cardiovascular Disease Prevention12▲ 89×1 topic
- Cholesterol-lowering12▲ 140×1 topic
- Percutaneous Coronary Intervention11▲ 45×3 topics
- Aspirin11▲ 223×1 topic
- Clopidogrel11▲ 223×1 topic
- Metabolic Syndrome11▲ 7.4×11 topics
- Hypertension10▲ 18×8 topics
- Diabetes9▲ 11×8 topics
- Cytochrome P4508▲ 64×2 topics
- Arachidonic Acid8▲ 139×1 topic
- Biomarkers8▲ 7.3×5 topics
- Epoxyeicosatrienoic Acids8▲ 139×1 topic
- Cholesterol7▲ 23×3 topics
- Thrombosis7▲ 19×5 topics
- Reactive Oxygen Species7▲ 8.3×6 topics
- Insulin Resistance6▲ 8.3×7 topics
- Endothelial Dysfunction6▲ 12×8 topics
- Lipid Peroxidation6▲ 46×2 topics
- Antioxidants5▲ 7.4×5 topics
- Magnetic Resonance Imaging5▲ 8.1×3 topics
- Cardiovascular Risk Assessment5▲ 29×2 topics
- Hemostasis5▲ 19×3 topics
- Transcriptional Regulation5▲ 11×3 topics
- Nuclear Receptors4▲ 14×3 topics
Which research topics does Austrian Atherosclerosis Society publish most on?
By volume in 2022–2025: Fungal Plant Pathogen Control, Multiple Sclerosis Research Studies, Retinal and Optic Conditions and Blood Coagulation and Thrombosis Mechanisms.
- 1 Fungal Plant Pathogen Control Ecology, Evolution, Behavior and Systematics 0 works
- 2 Multiple Sclerosis Research Studies Pathology and Forensic Medicine 0 works
- 3 Retinal and Optic Conditions Ophthalmology 0 works
- 4 Blood Coagulation and Thrombosis Mechanisms Hematology 0 works
- 5 Renal Diseases and Glomerulopathies Nephrology 0 works
- 6 Complement system in diseases Immunology 0 works
- 7 Powdery Mildew Fungal Diseases Plant Science 0 works
- 8 Vasculitis and related conditions Pulmonary and Respiratory Medicine 0 works
- 9 Multiple Myeloma Research and Treatments Hematology 0 works
- 10 Cardiovascular Conditions and Treatments Radiology, Nuclear Medicine and Imaging 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Austrian Atherosclerosis Society's research output changed?
Output in 2018–2022 was 46% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Vienna
- University of Vienna
- TU Wien
- Medical University of Vienna
- BOKU University
- Vienna University of Economics and Business
- Austrian Academy of Sciences
- University of Veterinary Medicine Vienna
- Austrian Institute of Technology
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.